The Hemophilia & Thrombosis Center of the University of Colorado, in collaboration with Children’s Hospital Colorado, strives to provide unparalleled access to the highest quality care, education, research and pharmacy services for patients with bleeding and clotting disorders in the Rocky Mountain region through teamwork, partnership with patients and families, and focus on continuous improvement.
The HTC will be a national leader in defining best clinical outcomes for patients, while integrating changes in the health care system, and forwarding research and education.
With the conviction to fulfill our Mission and determination to reach our Vision, the HTC embodies the following core values in our pursuit of excellence: teamwork, respect, integrity, resilience and innovation, to create an environment where together we will all make a difference in the lives of those affected by bleeding and clotting disorders.
The Objectives of the Hemophilia & Thrombosis Center program are to:
Provide comprehensive diagnostic, treatment, education and consultative services for patients with hemophilia and thrombosis disorders and their families in the Rocky Mountain region.
Provide education for physicians and other professionals involved in caring for persons with bleeding and clotting disorders.
Conduct specialized research in coagulation disorders.